PP_1170x120_10-25-21

Tom Wiggans

Dermira gets FDA approval for Qbrexza cloth

Dermira gets FDA approval for Qbrexza cloth

MENLO PARK, Calif. — Dermira announced that the U.S. Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older. Primary axillary hyperhidrosis, also commonly known as excessive underarm sweating, is a chronic medical skin condition

Adheris Health